Testosterone Treatment in Men With Chronic Kidney Disease
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This study in being conducted in men who have low testosterone and chronic kidney disease.
The investigators will evaluate the effects of an oral testosterone preparation, JATENZO, on
testosterone levels and hemoglobin (red blood cells).